Magnetar Financial LLC Sells 5,049 Shares of The Pennant Group, Inc. $PNTG

Magnetar Financial LLC trimmed its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 40.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,527 shares of the company’s stock after selling 5,049 shares during the quarter. Magnetar Financial LLC’s holdings in The Pennant Group were worth $225,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Cubist Systematic Strategies LLC increased its holdings in shares of The Pennant Group by 205.9% during the first quarter. Cubist Systematic Strategies LLC now owns 97,527 shares of the company’s stock worth $2,453,000 after purchasing an additional 65,640 shares during the period. Belpointe Asset Management LLC acquired a new stake in The Pennant Group during the second quarter worth approximately $211,000. Mackenzie Financial Corp grew its position in The Pennant Group by 25.2% during the first quarter. Mackenzie Financial Corp now owns 22,446 shares of the company’s stock worth $565,000 after buying an additional 4,522 shares in the last quarter. XTX Topco Ltd bought a new position in The Pennant Group during the 1st quarter worth $285,000. Finally, Pinnacle Associates Ltd. acquired a new position in The Pennant Group in the 2nd quarter valued at $1,104,000. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Stock Up 0.1%

Shares of NASDAQ PNTG opened at $28.09 on Thursday. The company has a market cap of $971.63 million, a price-to-earnings ratio of 37.45, a PEG ratio of 2.27 and a beta of 1.39. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The Pennant Group, Inc. has a 12 month low of $21.18 and a 12 month high of $32.00. The stock has a 50-day moving average price of $25.12 and a two-hundred day moving average price of $25.78.

The Pennant Group (NASDAQ:PNTG) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01. The business had revenue of $229.04 million during the quarter, compared to the consensus estimate of $221.96 million. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, analysts forecast that The Pennant Group, Inc. will post 0.75 earnings per share for the current fiscal year.

Analyst Ratings Changes

PNTG has been the topic of several analyst reports. Stephens reissued an “overweight” rating and set a $40.00 target price on shares of The Pennant Group in a report on Thursday, October 9th. Wall Street Zen upgraded shares of The Pennant Group from a “hold” rating to a “buy” rating in a research note on Monday. Royal Bank Of Canada raised their target price on shares of The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a report on Monday, November 17th. Zacks Research raised shares of The Pennant Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 20th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of The Pennant Group in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $33.60.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.